EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Enteral feeding during cyclooxygenase inhibitor treatment for patent ductus arteriosus: A systematic review

Gakuto Ujiie, Eriko Kobayashi iD, Miyuki Inoue, Motoichiro Sakurai, Yuko Sakurai, Kosuke Tanaka iD, Tetsuya Isayama, Katsuaki Toyoshima

Pediatrics International · 2026-01 · 68 (1)

DOI: 10.1111/ped.70338 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pediatrics International, online erschienen am 10.02.2026. Verfasst von Gakuto Ujiie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Showa Medical University, Shinagawa, Japan. Hauptthemen laut MEDLINE: Ductus Arteriosus, Patent, Enteral Nutrition, Cyclooxygenase Inhibitors, Infant, Premature, Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study evaluated the effect of modifying enteral feeding during cyclooxygenase inhibitor (COXI) treatment on patent ductus arteriosus (PDA) in preterm infants.

Methods

We searched MEDLINE, EMBASE, CENTRAL, CINAHL, and ICHUUSHI databases for randomized and nonrandomized controlled trials, checked the references lists and major clinical trials. Non‐human and non‐English studies were excluded. Evidence was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation. Preterm infants born before 37 weeks of gestation are treated with COXIs for PDA, including indomethacin and ibuprofen. The primary outcomes were the composite outcome of necrotizing enterocolitis (NEC) or gastrointestinal perforation and its components (NEC and gastrointestinal perforation).

Results

Two randomized controlled trials ( n = 303) and one retrospective cohort study ( n = 261) were included (total: n = 564). No significant differences were observed in the composite gastrointestinal outcome (risk ratio [RR]: 1.10, 95% confidence interval [CI]: 0.51–2.37; 1 study, 177 infants, very low certainty of evidence [CoE]), NEC (RR: 1.01, 95% CI: 0.47–2.15; 2 studies, 300 infants, very low CoE), or gastrointestinal perforation (RR: 1.94, 95% CI: 0.25–14.81; 2 studies, 300 infants, very low CoE) between discontinuation and continuation of enteral feeding. Discontinuation of enteral feeding resulted in a significantly lower rate of surgical closure for PDA compared to continuation (RR: 0.56, 95% CI: 0.37–0.86; 1 study, 177 infants, low CoE).

Conclusions

Neither discontinuation nor continuation of enteral feeding significantly affected the composite gastrointestinal outcome and its components (NEC and gastrointestinal perforation).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ductus Arteriosus, PatentEnteral NutritionCyclooxygenase InhibitorsInfant, Premature, DiseasesHumansInfant, NewbornInfant, PrematureEnterocolitis, NecrotizingIntestinal PerforationIbuprofenIndomethacin

Stichwörter der Autor:innen

cyclooxygenase inhibitorsenteral nutritionnecrotizing enterocolitispatent ductus arteriosuspreterm infants

Substanzen

Cyclooxygenase InhibitorsIbuprofenIndomethacin

Autor:innen und Institutionen

  • Department of Pediatrics, Showa Medical University, Shinagawa, Japan.
  • Department of Neonatology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Department of Nursing, Toyama Prefectural University, Imizu, Japan.
  • Department of Nursing Faculty of Human Health Sciences, Shunan University, Shunan, Japan.
  • Department of Neonatology, Kameda Medical Center, Kamogawa, Japan.
  • Division of Neonatology, Department of Pediatrics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.

ORCID-Profile: Eriko Kobayashi, Kosuke Tanaka

Zitieren

APA

Ujiie, G., Kobayashi, E., Inoue, M., Sakurai, M., Sakurai, Y., Tanaka, K., Isayama, T., & Toyoshima, K. (2026). Enteral feeding during cyclooxygenase inhibitor treatment for patent ductus arteriosus: A systematic review. Pediatrics International, 68(1). https://doi.org/10.1111/ped.70338

Vancouver

Ujiie G, Kobayashi E, Inoue M, Sakurai M, Sakurai Y, Tanaka K, et al. Enteral feeding during cyclooxygenase inhibitor treatment for patent ductus arteriosus: A systematic review. Pediatrics International. 2026;68(1). doi:10.1111/ped.70338

BibTeX
@article{Ujiie2026,
  author = {Ujiie, Gakuto and Kobayashi, Eriko and Inoue, Miyuki and Sakurai, Motoichiro and Sakurai, Yuko and Tanaka, Kosuke and Isayama, Tetsuya and Toyoshima, Katsuaki},
  title = {Enteral feeding during cyclooxygenase inhibitor treatment for patent ductus arteriosus: A systematic review},
  journal = {Pediatrics International},
  year = {2026},
  volume = {68},
  number = {1},
  doi = {10.1111/ped.70338}
}
Kostenlos starten →